rawfin.tv
United Therapeutics CEO Sells 9,500 Shares After Option Exercise
MarketsstocksAI Generated

United Therapeutics CEO Sells 9,500 Shares After Option Exercise

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Martine A. Rothblatt, CEO of United Therapeutics Corp (UTHR), exercised 9,500 stock options and subsequently sold the shares. This transaction is part of an executive's compensation and stock management.

United TherapeuticsInsider TradingExecutive StockBiotechOption Exercise

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks